Back to search results

Observational Study of Electrical Impedance Tomography (EIT) for Lung Health

This study is looking at a new way to examine your lungs using a machine called Electrical Impedance Tomography (EIT). EIT is a device that uses electrodes, similar to those used for an EKG (a test that checks your heart's electrical activity), to create images of your lungs. Unlike X-rays or CT scans, EIT does not use radiation. Researchers want to compare EIT images from people with long-term breathing problems (like those from prematurity or heart conditions) to those without these problems. This will help them understand more about how lungs are structured and how they work. The study is open to individuals aged 2 weeks to 25 years who have certain cardiopulmonary (heart and lung) conditions.

Study design
This is an observational study planning to include 140 participants. It compares EIT results between individuals with and without chronic respiratory disease.
What's involved
You would have EIT imaging maps taken to provide information about your lung ventilation and perfusion. This measurement is taken at 4 hours.
Compensation
Not stated in the trial record.
Follow-up
EIT imaging maps are measured at 4 hours.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07247474

Triple EIT (Electrical Impedance Tomography)

Recruiting
Not specifiedAges 2–25Observational
University of Colorado, Denver
~140 participants
Updated 2026-02-23 on ClinicalTrials.gov
What's tested:Electrical impedance tomography (EIT)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
EIT Imaging Maps that provide information about regional ventilation and perfusion of the lung
Measured over 4 hours

Conditions

Neonates and Preterm Infants
Cardiopulmonary

Explore related trials

Congenital Diaphragmatic HerniaCongenital Heart DiseaseCor PulmonaleDevelopmental or congenital lung diseaseNeuromuscular DisorderPost-prematurity respiratory diseasePulmonary HypertensionRespiratory Failure

Where it's being run

1 sites across 1 states
Colorado1

Study leadership

  • Katelyn Enzer, MD · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Who to contact

Katelyn Enzer, MD
[email protected]
7207779137
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

2 weeks to 25 years of age
evidence of cardiopulmonary disease including, but not limited to:

Exclusion

\<2 weeks of age
Anything that interferes with lead placement on the chest wall (such as, dermatologic conditions, multiple chest tubes, anatomic abnormality, or large dressings that cannot be moved)
No informed consent
Pregnant or lactating
Pacemaker or other metal intrathoracic surgical implant (causes noise in the data)

What this trial measures

  • EIT Imaging Maps that provide information about regional ventilation and perfusion of the lung4 hours

    These images will be analyzed both visually for qualitative abnormalities and through quantitative pixel analysis that can provide information regarding lung volume, blood volume, and changes in either based on respiratory cycle, cardiac cycle, or intervention. Areas of low ventilation (atelectasis and consolidation) will be identified.